Both in Surgical Instruments
SI-BONE vs SpyGlass Pharma
Over the past year SIBN returned +22.8% and SGP returned −3.6%; their daily moves had a correlation of 0.21.
SIBN +22.8% SGP −3.6%Growth of $1, one year, split-adjusted
| Metric | SIBN | SGP |
|---|---|---|
| Price | $19.15 | $25.44 |
| Market cap | $858.3M | $850.9M |
| Today | +2.08% | −2.08% |
| 1 month | −0.3% | −3.7% |
| 6 months | +55.9% | +8.9% |
| Year to date | −2.9% | — |
| 1 year | +36.3% | — |
| Revenue growth (YoY) | +15.2% | — |
| Gross margin | 79.5% | — |
| Net margin | −7.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.0× | — |
| Net cash | $110.3M | $234.2M |
| Dividend yield | — | — |
| Volatility (60d) | 31.2% | 53.0% |
| Short % of float | 13.7% | 20.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).